Please use this identifier to cite or link to this item:
|Title:||The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders|
Sweet, Robert A.
Roy Chengappa, Kadiamada N.
Reddy, Ravinder R.
Jeste, Dilip V.
|Keywords:||Aging -- Health aspects|
|Publisher:||John Wiley & Sons Ltd.|
|Citation:||Mamo, D. C., Sweet, R. A., Roy Chengappa, K. N., Reddy, R. R., & Jeste, D. V. (2002). The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. International Journal of Geriatric Psychiatry, 17(11), 1012-1017.|
|Abstract:||Background Cross-sectional studies indicate that, in comparison to younger patients, older schizophrenic patients have a higher risk for neuroleptic-induced Parkinsonism and tardive dyskinesia (TD). It has been suggested, therefore, that older patients with schizophrenia could be maintained on reduced doses of conventional neuroleptics. Method We examined the effect of age on psychopharmacological management in a naturalistic study of a group of 165 patients with a clinical diagnosis of schizophrenia or a related psychotic disorder (age range=21–84 years; subjects ≥1;45 years n=86) treated with either haloperidol decanoate or fluphenazine decanoate. Results Increasing age was not correlated with total daily dose of neuroleptics or anticholinergic medication. However, a modest negative correlation of age with daily neuroleptic dose was found in patients aged 45 years and older. Conclusion The results of this study highlight the need for prospective assessments of depot neuroleptic dose requirements in older patients suffering from primary psychotic disorders.|
|Appears in Collections:||Scholarly Works - FacM&SPsy|
Files in This Item:
|95.07 kB||Adobe PDF||View/Open Request a copy|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.